Efficiency ratio and rocketing drug prices: old concerns and new possibilities

European Journal of Health Economics

23 October 2020 - One of the most significant phenomena in the recent years concerning the pharmaceutical industry and, at the same time, payers in health care systems, is the sharp acceleration in the growth of new drug prices.

Sustainability is being discussed across the board and every healthcare system deals with it in different ways, in particular pricing and reimbursement mechanisms.

Read European Journal of Health Economics Editorial

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , Europe , Pricing , Value